Schedule 13G ownership disclosure
ROIVANT SCIENCES LTD SHS
Common Shares, par value $0.0000000341740141 per share · CUSIP: G76279101
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SB Investment Advisers (UK) Limited
Shares: 16,413,603.00 · Class: 2.3%
- SoftBank Vision Fund L.P.
Shares: 16,413,603.00 · Class: 2.3%
- SVF Holdings (UK) LLP
Shares: 16,413,603.00 · Class: 2.3%
- SVF Investments (UK) Limited
Shares: 16,413,603.00 · Class: 2.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-007176
- Form type
- SCHEDULE 13G/A
- Filer
- Roivant Sciences Ltd.
- CIK
- CIK 1635088
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership